Literature DB >> 27190797

Implication of Renal Aquaporin-3 in Fructose-Induced Metabolic Syndrome and Melatonin Protection.

Suzy Fayez Ewida1, Dalia Rifaat Al-Sharaky2.   

Abstract

INTRODUCTION: Metabolic Syndrome (MetS) can be induced by ingestion of large amounts of fructose as a consequence of oxidative stress and dyslipidemia. AIM: We investigated the possible protective effects of melatonin administration on MetS induced in fructose-fed rats with special focus on the role of renal aquaporin-3 (AQP-3).
MATERIALS AND METHODS: Thirty rats were randomly divided into three groups; control, fructose, and fructose plus melatonin. MetS was induced by fructose rich diet and melatonin was injected at a dose of 5 mg/kg dissolved in 1% ethanol in normal saline. After the end of the 6-week experimental period, body weight and fat accretion were assessed. Invasive blood pressure and vascular reactivity were evaluated. Serum lipid profile, glucose, insulin levels, insulin resistance, malondialdehyde (MDA) and uric acid were measured, also underwent renal AQP-3 immunohistochemistry.
RESULTS: Fructose consumption significantly increased fat accretion, systolic blood pressure, serum lipids, insulin levels and insulin resistance, confirming successful establishment of the MetS model. Also serum MDA, uric acid and renal AQP-3 expression increased compared to the control group. Melatonin supplementation significantly decreased the previously measured parameters compared to fructose group.
CONCLUSION: Increased AQP-3 expression may be implicated in fructose induced MetS. Melatonin protective effect against metabolic consensus and vascular affection may be linked to its antioxidant and lipid lowering effect with reduced renal AQP-3 expression.

Entities:  

Keywords:  Aquaglyceroporin-3; Fructose; Insulin resistance; Vascular reactivity

Year:  2016        PMID: 27190797      PMCID: PMC4866095          DOI: 10.7860/JCDR/2016/18362.7656

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  33 in total

1.  Remnant-like particles accelerate endothelial progenitor cells senescence and induce cellular dysfunction via an oxidative mechanism.

Authors:  Ling Liu; Tie Wen; Xiao-yan Zheng; De-Guang Yang; Shui-Ping Zhao; Dan-Yan Xu; Guo-hua Lü
Journal:  Atherosclerosis       Date:  2008-05-22       Impact factor: 5.162

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Permeability of pure lipid bilayers to melatonin.

Authors:  E J Costa; R H Lopes; M T Lamy-Freund
Journal:  J Pineal Res       Date:  1995-10       Impact factor: 13.007

4.  Abnormal aquaporin-3 protein expression in hyperproliferative skin disorders.

Authors:  Kristen E Voss; Roni J Bollag; Nicole Fussell; Charya By; Daniel J Sheehan; Wendy B Bollag
Journal:  Arch Dermatol Res       Date:  2011-03-13       Impact factor: 3.017

Review 5.  Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities?

Authors:  F Nduhirabandi; E F du Toit; A Lochner
Journal:  Acta Physiol (Oxf)       Date:  2012-02-03       Impact factor: 6.311

6.  Melatonin improves metabolic syndrome induced by high fructose intake in rats.

Authors:  Akira Kitagawa; Yoshiji Ohta; Koji Ohashi
Journal:  J Pineal Res       Date:  2012-01-06       Impact factor: 13.007

7.  Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose.

Authors:  R G Judzewitsch; M A Pfeifer; J D Best; J C Beard; J B Halter; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

8.  The effect of high-fructose intake on the vasopressor response to angiotensin II and adrenergic agonists in Sprague-Dawley rats.

Authors:  Mohammed Hadi Abdulla; Munavvar Abdul Sattar; Nor Azizan Abdullah; Edward James Johns
Journal:  Pak J Pharm Sci       Date:  2013-07       Impact factor: 0.684

9.  Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial.

Authors:  Abhinav Goyal; Paul D Terry; Hillary M Superak; Christine L Nell-Dybdahl; Ritam Chowdhury; Lawrence S Phillips; Michael H Kutner
Journal:  Diabetol Metab Syndr       Date:  2014-11-18       Impact factor: 3.320

10.  Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients.

Authors:  Abeer A Bahnassy; Abdel-Rahman N Zekri; Soumaya El-Houssini; Amal M R El-Shehaby; Moustafa Raafat Mahmoud; Samira Abdallah; Mostafa El-Serafi
Journal:  BMC Gastroenterol       Date:  2004-09-23       Impact factor: 3.067

View more
  4 in total

Review 1.  Melatonin, mitochondria, and the metabolic syndrome.

Authors:  Daniel P Cardinali; Daniel E Vigo
Journal:  Cell Mol Life Sci       Date:  2017-08-17       Impact factor: 9.261

2.  The role of AQP3 and AQP4 channels in cisplatin-induced cardiovascular edema and the protective effect of melatonin.

Authors:  Lokman Koral; Mehmet Akif Ovali; Nezahat Kubra Tufekcioglu; Ersen Karakilic; Yasemen Adali; Metehan Uzun
Journal:  Mol Biol Rep       Date:  2021-10-16       Impact factor: 2.316

Review 3.  Potential Crosstalk between Fructose and Melatonin: A New Role of Melatonin-Inhibiting the Metabolic Effects of Fructose.

Authors:  Francisco J Valenzuela-Melgarejo; Claudia Caro-Díaz; Gerardo Cabello-Guzmán
Journal:  Int J Endocrinol       Date:  2018-08-01       Impact factor: 3.257

Review 4.  Evidence for the Benefits of Melatonin in Cardiovascular Disease.

Authors:  Mohammad Tobeiha; Ameneh Jafari; Sara Fadaei; Seyed Mohammad Ali Mirazimi; Fatemeh Dashti; Atefeh Amiri; Haroon Khan; Zatollah Asemi; Russel J Reiter; Michael R Hamblin; Hamed Mirzaei
Journal:  Front Cardiovasc Med       Date:  2022-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.